COL1A1 and Hepatic fibrosis: Overall, this study greatly enriched the anti-COL1A1 SAR of the tricyclic matrinic derivatives and thus offered powerful information for further structure optimization, noting that compound 8a was chosen as an ideal anti-liver fibrosis lead.